Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 PGx Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in precision medicine to highlight their contributions to the field.
Confirmed Presenting Companies:
Speaker Profile
Ph.D., CEO, GeneLeap
Biography
Tod Klingler, PhD, is a visionary leader in genomics and personalized healthcare with deep expertise in machine learning, molecular diagnostics, and big data analytics. With a proven track record of founding and scaling successful start-ups, he has developed cutting-edge solutions that advance precision medicine. His leadership has driven innovations in genomics testing, personalized health programs, and data-driven healthcare platforms. As an experienced product strategist, Tod excels at integrating advanced medical technologies to enhance disease prevention, precise diagnostics, and treatment optimization, making a significant impact on healthcare outcomes worldwide.
Talk
Leveraging Genomics and AI to Personalize Drug Therapy
This talk will describe how GeneLeap's innovative platform combines generative AI structure prediction advancements combined with an individual's genetics to optimize drug therapies. By predicting drug response, side effects and metabolic interactions, this technology promises to provide tailored treatment recommendation and mitigate therapeutic odysseys.
Pharmacogenomics Showcase:
GeneLeap, Inc.
GeneLeap is developing a generative AI-based platform to optimize drug therapies for individuals with depression. The platform will generate treatment recommendations using an individual's genetic makeup with the goal of improving treatment outcomes by reducing the trial-and-error process often encountered in psychiatric care.
Speaker Profile
PHARMD, VP Clinical & Product, Seegnal eHealth
Biography
Over 20 years of experience in clinical pharmacy, academia, and management.Served as the Chief Clinical Pharmacist at Maccabi Healthcare Services, Israels second-largest HMO, leading pivotal and impactful projects that empowered clinicians, pharmacists, and other healthcare professionals to improve the safety and quality of drug treatment across the organization. Additionally, spearheaded numerous national initiatives in collaboration with the Israeli Ministry of Health, with a focus on managing drug-related problems, enhancing healthcare quality measures, and advancing patient care
Talk
Practical Precision Medication: PGx-Enhanced Solution for Clinicians
Healthcare is shifting toward personalized patient care. Pharmacogenomics-a key tool in this shift- helps tailor treatments by incorporating genetic information, which alongside all other patientsdrugs parameters provides the physician with a comprehensive view to optimize drug choices, overcoming usability challenges that pave the way for faster adoption of precision medicine.
Pharmacogenomics Showcase:
Seegnal eHealth
Seegnal® is a patient-tailored, PGx-enhanced, decision-support tool integrated into the electronic medical record that operates in real-time at the point of care. Designed to address drug-related problems (DRPs) comprehensively, it analyses multiple DRP domains—including pharmacogenetics—enabling clinicians to detect, prioritize, and resolve DRPs intuitively and efficiently.
